PRODUCTS
INFECTIOUS DISEASE TESTS ::
C.pneumoniae
Ani Labsystems offers species-specific tests
for Chlamydia pneumoniae IgG, IgA and IgM
antibodies based on the latest enzyme
immunoassay (EIA) technology as well as on
micro immunofluorescence methodology (MIFA).
Micro immunofluorescence has an established
position as a standard method in C.
pneumoniae serology. Ani Labsystems’ C.
pneumoniae IgG/IgM MIFA and C. pneumoniae
IgA MIFA have the following characteristics:
|
|
C. pneumoniae , C. trachomatis and C.
psittaci/LPS antigens available. No egg yolk
control needed. |
|
|
Group-specific LPS reaction eliminated. |
|
|
Parallel antigen dot positioning for
easier reading, all three antigens in one
well. |
|
|
Optimal particle (EB) density for easier
reading and interpretation. |
|
|
Ready-for-use reagents in dropper bottles. |
|
|
Two kit sizes – 20 x 21 wells and 20 x 12
wells. |
Ani Labsystems’ convenient C. pneumoniae
IgG, IgA and IgM EIA kits are superior with
sensitivity and reproducibility. The kits
include ready-for-use reagents. They offer
following advantages over MIFA:
|
|
Higher throughput |
|
|
Semi-quantitative results (IgG, IgA) |
|
|
Objective reading |
|
|
More reproducible results |
|
|
More accurate discrimination between past
and reinfection |
Mycoplasma pneumoniae EIAs, Chlamydia
pneumoniae EIAs and Bordetella pertussis
EIAs use the same format, procedure and
sample predilution.
|
